ESAB India Intrinsic Value
ESABINDIA • Industrial Products
Current Stock Price
₹4955.50
Primary Intrinsic Value
₹1641.60
Market Cap
₹7433 Cr
-66.9%
Downside
Median Value
₹1641.60
Value Range
₹991 - ₹2478
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
ESABINDIA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1641.60 | ₹1313.28 - ₹1969.92 | -66.9% | EPS: ₹136.80, Sector P/E: 12x |
| Book Value Method | asset | ₹991.10 | ₹891.99 - ₹1090.21 | -80.0% | Book Value/Share: ₹240.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1486.65 | ₹1337.99 - ₹1635.32 | -70.0% | Revenue/Share: ₹1011.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1982.20 | ₹1783.98 - ₹2180.42 | -60.0% | EBITDA: ₹296.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1982.20 | ₹1585.76 - ₹2378.64 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2188.80 | ₹1969.92 - ₹2407.68 | -55.8% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1486.65 | ₹1337.99 - ₹1635.32 | -70.0% | Revenue Growth: 13.9%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹2477.75 | ₹2229.97 - ₹2725.53 | -50.0% | ROE: 58.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1486.65 | ₹1337.99 - ₹1635.32 | -70.0% | EPS: ₹136.80, BVPS: ₹240.67 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
ESABINDIA Intrinsic Value Analysis
What is the intrinsic value of ESABINDIA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of ESAB India (ESABINDIA) is ₹1641.60 (median value). With the current market price of ₹4955.50, this represents a -66.9% variance from our estimated fair value.
The valuation range spans from ₹991.10 to ₹2477.75, indicating ₹991.10 - ₹2477.75.
Is ESABINDIA undervalued or overvalued?
Based on our multi-method analysis, ESAB India (ESABINDIA) appears to be trading above calculated value by approximately 66.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 39.58 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 58.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.34x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for ESAB India
Additional stock information and data for ESABINDIA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹200 Cr | ₹192 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹141 Cr | ₹114 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹129 Cr | ₹129 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹85 Cr | ₹85 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹72 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |